# Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

> **NCT04542330** · PHASE3 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 1700 (actual)

## Conditions studied

- Covid19
- Non-specific Effects of Vaccines
- Heterologous Immunity
- Morbidity
- Immunosenescence
- Vaccine Preventable Disease

## Interventions

- **BIOLOGICAL:** BCG-Denmark
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT04542330
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2023-01-11
- **Final completion:** 2023-01-11
- **Target enrollment:** 1700 (ACTUAL)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542330, "Using BCG to Protect Senior Citizens During the COVID-19 Pandemic". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04542330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*